Paroxysmal exertion-induced dyskinesia Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Mar 2026Surgical vs Endoscopic Resection of Walled Off Pancreatic Necrosis Using the Powered Endoscopic Debridement System

Stanford University — NA

TrialNOT YET RECRUITING

Jan 2026Effectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis

Assistance Publique - Hôpitaux de Paris — NA

TrialRECRUITING

Jun 2025Timing of Aminophylline and Recovery in Pediatric Ambulatory Surgery

Hany Mohammed El-Hadi Shoukat Mohammed — PHASE3

TrialNOT YET RECRUITING

May 2025Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

MSD Italia S.r.l.

TrialRECRUITING

Apr 2025Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry

Sarasota Memorial Health Care System

TrialENROLLING BY INVITATION

Mar 2025Videoconferencing for the Management of Paediatric Dyspnoea in an Emergency Medical Call Centre

Poitiers University Hospital — NA

TrialRECRUITING

Jul 2024QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

SeaStar Medical

TrialRECRUITING

Mar 2024LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

Wake Forest University Health Sciences — NA

TrialRECRUITING

Aug 2023A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Glaukos Corporation — PHASE2

TrialRECRUITING

Oct 2019A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

GlaxoSmithKline — PHASE1, PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Paroxysmal exertion-induced dyskinesia.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Gocovri

(Amantadine hydrochloride)Orphan drug

Adamas Pharmaceuticals, Inc.

Influenza A M2 Protein Inhibitor [EPC]

12.1 Mechanism of Action The mechanism by which amantadine exerts efficacy in the treatment of dyskinesia in patients with Parkinson's disease or as a...

Approved Aug 2017FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Paroxysmal exertion-induced dyskinesia.
Search all trials →

Search clinical trials for Paroxysmal exertion-induced dyskinesia →

Recent News & Research

No recent news articles indexed yet for Paroxysmal exertion-induced dyskinesia.
Search PubMed for Paroxysmal exertion-induced dyskinesia →

Browse all Paroxysmal exertion-induced dyskinesia news →

Specialist Network

Top 1 by expertise

Pascal AMEDRO, MD-PhD, MD, PhD

UH MONTPELLIER

📍 WASHINGTON, DC

Score 33 trials

View all Paroxysmal exertion-induced dyskinesia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰